Allogeneic hematopoietic stem cell transplantation for non-malignant hematological disorders

Allogeneic hematopoietic stem cell transplantation (allo-HSCT) from a geno-identical matched sibling (MSD) is one of the most successful therapies in patients with non-malignant hematological disorders. This study included 273 patients with severe aplastic anemia (SAA), 152 patients with B-Thalassem...

Descripción completa

Detalles Bibliográficos
Autores principales: Mahmoud, Hossam K., Elhaddad, Alaa M., Fahmy, Omar A., Samra, Mohamed A., Abdelfattah, Raafat M., El-Nahass, Yasser H., Fathy, Gamal M., Abdelhady, Mohamed S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2015
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4522586/
https://www.ncbi.nlm.nih.gov/pubmed/26257943
http://dx.doi.org/10.1016/j.jare.2014.11.001

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4522586/
https://www.ncbi.nlm.nih.gov/pubmed/26257943
http://dx.doi.org/10.1016/j.jare.2014.11.001

Ejemplares similares